Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Cancer Immunology, Immunotherapy : CII|September 16, 2008
Prognostic significance of tumor-infiltrating T-lymphocytes in primary and metastatic lesions of advanced stage ovarian cancerNinke Leffers, Marloes J M Gooden, Renske A de Jong, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 10, 2011
Tumor-infiltrating cytotoxic T lymphocytes as independent prognostic factor in epithelial ovarian cancer with wilms tumor protein 1 overexpressionRenee Vermeij, Geertruida H de Bock, Ninke Leffers, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 18, 2007
Serum cytokine profiling as a diagnostic and prognostic tool in ovarian cancer: a potential role for interleukin 7Annechien J A Lambeck, Anne P G Crijns, Ninke Leffers, et al.
International Journal of Cancer|September 4, 2009
The prognostic role of classical and nonclassical MHC class I expression in endometrial cancerClaudia B M Bijen, Enja J Bantema-Joppe, Renske A de Jong, et al.
International Journal of Cancer|April 7, 2007
P53-specific T cell responses in patients with malignant and benign ovarian tumors: implications for p53 based immunotherapyAnnechien Lambeck, Ninke Leffers, Baukje-Nynke Hoogeboom, et al.
Oncoimmunology|September 14, 2020
Deep immune profiling of ovarian tumors identifies minimal MHC-I expression after neoadjuvant chemotherapy as negatively associated with T-cell-dependent outcomeKim L Brunekreeft, Sterre T Paijens, Maartje C A Wouters, et al.
International Journal of Cancer|December 6, 2011
Potentiation of a p53-SLP vaccine by cyclophosphamide in ovarian cancer: a single-arm phase II studyRenee Vermeij, Ninke Leffers, Baukje-Nynke Hoogeboom, et al.
Oncotarget|September 22, 2016
CD103+ intraepithelial T cells in high-grade serous ovarian cancer are phenotypically diverse TCRαβ+ CD8αβ+ T cells that can be targeted for cancer immunotherapyFenne L Komdeur, Maartje C A Wouters, Hagma H Workel, et al.
International Journal of Cancer|July 22, 2009
Immunization with a P53 synthetic long peptide vaccine induces P53-specific immune responses in ovarian cancer patients, a phase II trialNinke Leffers, Annechien J A Lambeck, Marloes J M Gooden, et al.
Pageof 2